{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T21:17:46Z","timestamp":1787779066023,"version":"build-2784847793"},"reference-count":5,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jacl.2026.04.011","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:44:49Z","timestamp":1787575489000},"page":"1735-1736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Remnant cholesterol and diabetic kidney disease phenotypes: The importance of albuminuria-stratified interpretation"],"prefix":"10.1016","volume":"20","author":[{"given":"Ying","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangqing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2026.04.011_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jacl.2025.10.075","article-title":"Remnant cholesterol and kidney disease progression in type 2 diabetes: a retrospective cohort study","volume":"20","author":"Mori","year":"2026","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.04.011_bib2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2337\/dc19-1438","article-title":"Risk of rapid kidney function decline, all-cause mortality, and major cardiovascular events in nonalbuminuric chronic kidney disease in type 2 diabetes","volume":"43","author":"Buyadaa","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2026.04.011_bib3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00125-021-05590-5","article-title":"Kidney outcomes and all-cause mortality in people with type 2 diabetes exhibiting non-albuminuric kidney insufficiency","volume":"65","author":"Yamamoto","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacl.2026.04.011_bib4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/j.ajkd.2021.11.011","article-title":"Nonalbuminuric diabetic kidney disease and risk of all-cause mortality and cardiovascular and kidney outcomes in type 2 diabetes: findings from the Hong Kong Diabetes Biobank","volume":"80","author":"Jin","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacl.2026.04.011_bib5","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/joim.13298","article-title":"Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetes","volume":"290","author":"Jansson Sigfrids","year":"2021","journal-title":"J Intern Med"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426001169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426001169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:22:36Z","timestamp":1787775756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287426001169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":5,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1933287426001169"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.04.011","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remnant cholesterol and diabetic kidney disease phenotypes: The importance of albuminuria-stratified interpretation","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}